His research interests address all aspects of the management of plasma cell dyscrasias (multiple myeloma, monoclonal gammopathy of undetermined significance, amyloidosis, and Waldenstrom’s macroglolinemia). Dr. Vesole has more than 25 years of clinical research experience in plasma cell dyscrasias and stem cell transplantation and has produced over 200 peer-reviewed publications in these areas. He is a member of the scientific advisory board of the International Myeloma Foundation and a member of the International Myeloma Working Group.